• #Elsevier parent company reports 10% rise in profit, to £3.2bn

    Scientific arm of #Relx reports adjusted operating profit of £1.17 billion in 2024

    Relx, the parent company of academic publishing giant Elsevier, has reported a 10 per cent underlying growth in its adjusted operating profit for 2024, reaching just under £3.2 billion from revenues of £9.43bn.

    Within this, the scientific, technical and medical arm of the company—which includes its publishing business—had an adjusted operating profit of £1.17bn, with underlying growth of five per cent.

    This arm had revenue of £3.05bn, giving it an adjusted operating margin of 38.4 per cent, the company reported on 13 February.

    Relx said its primary research business “continued to be driven by volume growth, with article submissions growing very strongly across the portfolio, particularly in pay-to-publish”.

    Its financial results come amid concern among some politicians and research organisations about money being spent on publishing by publicly funded research. Last month, 10 European research organisations announced they would help to fund broader use of the EU’s free-to-publish publishing platform, Open Research Europe.

    Meanwhile, in the UK, Research Professional News has reported that the universities of Sheffield, Surrey and York have opted out of the sector-wide “big deal” with Elsevier, amid a bleak outlook on university finances and concerns over slow progress to fully open access publishing. An Elsevier spokesperson previously told RPN that Sheffield, York and Surrey “have all signed individual agreements [with the company] or are in discussions with us to continue access to Elsevier-published journals”.

    Publishing evolution a risk

    Among the risks Relx set out for investors, it said one was “evolution” in the scholarly publishing landscape.

    The open access publishing model “now represents a significant and growing portion of the volume of primary research that we publish”, it said, adding that “rapid changes in customer choice, regulation or technologies in this area could impact the revenue mix and growth”

    Relx added: “Maintaining research integrity requires us to manage risks around fraud in research papers in the context of evolving technologies.” It said that it operates “in highly competitive and dynamic markets”, which are affected by developments in technologies like artificial intelligence.

    More growth expected

    The company said it expects “good underlying revenue growth” in 2025, with growth in adjusted operating profit being slightly higher than the revenue growth.

    Chief executive officer Erik Engstrom said: “Our improving long-term growth trajectory continues to be driven by the ongoing shift in business mix towards higher growth analytics and decision tools that deliver enhanced value to our customers across market segments.”

    #profit #édition_scientifique #publications_scientifiques #business #ESR #recherche

    –-

    ajouté à la #métaliste sur la #publication_scientifique* :
    https://seenthis.net/messages/1036396

  • Academia in a stranglehold

    Academic publishers’ most valuable asset used to be their journals. Now, it’s the data they collect from researchers and then sell. That is extremely concerning, a growing group of Groningen researchers feels. ‘They control every part of the process and register every action you take.’

    When UG philosopher Titus Stahl is mulling over a new research topic, he has a range of tools available to help him get started. He could use academic search engine Scopus, for example, to point him to articles he could read online or download. He might also take notes using Mendeley, the useful software tool that helps you keep track of sources and references.

    If he then writes a grant proposal to get funding, there’s a good chance that the people assessing it use SciVal – software that analyses research trends, but also contains individual researchers’ citation and publication data.

    In the meantime, he could discuss his work on SSRN, a social platform used to share and peer-review early-stage research. And ultimately, of course, he’ll publish it in an open access magazine for which the university has paid article processing fees, or APCs, after which others will read it – at home, through their libraries, or again using Scopus.

    Then, finally, he will enter his article in Pure, the database the university uses to register all research done at the UG. His profile might change to reflect he has done research on a new topic. Affiliations may be added, since his network has changed too, so everyone can see who he collaborates with and what his strengths are.

    It’s all very streamlined and it all works beautifully. However, it doesn’t seem all that great anymore when you realise that every tool Stahl has been using, every platform on which he publishes, is owned by publishing mogul Elsevier. And Elsevier not only provides tools, it also collects user data. It logs everything Stahl does, every keystroke.

    ‘They know what you are working on, they know what you are submitting, they know the results of your peer reviews’, Stahl says. ‘They control every part of the process and register every action you take.’
    Everything is recorded

    And that gives them far more information than you might realise. When Eiko Fried, a psychologist from the University of Leiden, asked Elsevier for his personal data in December 2021, he received an email with hundreds of thousands of data points, going back many years.

    He discovered that Elsevier knew his name, his affiliations and his research. That his reviews had been registered, as well as the requests for peer review he had declined. Elsevier kept track of his IP-addresses – leading back to his home – his private telephone numbers, and the moments he logged in, which showed exactly when he worked and when he was on vacation. There were websites he visited, articles he had downloaded or just viewed online. Every click, every reference was recorded.

    Fried’s blog posts about this came as a shock and a revelation to Stahl. ‘It’s a long-term danger to academic freedom’, he says. ‘They control the academic process with an infrastructure that serves their interests, not ours. And they use the collected data to provide analytics services to whoever pays for them.’

    Stahl is one of a growing group of researchers inside and outside the University of Groningen who are concerned about the situation. He finds Oskar Gstrein on his side. ‘There is this ingrained power imbalance between the universities and the publishers’, says the data autonomy specialist with Campus Fryslân and the Jantina Tammes School of Digital Society, Technology and AI. ‘They own the journals people want to get into. And now they have taken over the whole publishing sphere.’

    In a recently published call for action, the Young Academy Groningen (YAG) and the Open Science Community Groningen, too, sounded the alarm. ‘It is time to formulate a long-term vision for a sustainable, independent higher education system’, they wrote. ‘We not only endorse this ambition but call on our university to reclaim ownership over our research output.’
    New business model

    They have reason to worry. Big publishers like Elsevier make billions of euros a year. Historically by publishing academic articles, but they have recently changed their business model. Now, they sell data connected to academic publishing. And that is ‘insanely profitable’, Stahl says.

    Profits of Elsevier’s parent company RELX rose to 10 percent in 2023 – 2 billion euros on a revenue of 10 billion. ‘Article submissions returned to strong growth, with pay-to-publish open-access articles continuing to grow particularly strongly’, RELX reported in February this year.

    Elsevier’s Erik Engstrom was the third highest paid CEO in the Netherlands between 2017 and 2020, earning over 30 million. Only the CEOs of Shell and another scientific publisher, Wolters Kluwer, earned more.

    Only a decade ago, it looked as if big publishers’ hold on academia was weakening. Universities and the Dutch government were done with first funding their research with public money, offering their papers for free to publishers like Elsevier (The Lancet, Cell), Springer (Nature) or Wiley (Advanced Materials), editing and peer reviewing those papers for free and then having to pay insane amounts of subscription fees to make those same papers available to their researchers again.

    They moved towards open access and as a result, 97 percent of the publications in Groningen is now published open access. ‘Their traditional business model no longer worked’, says Gstrein. ‘So publishers had to reinvent themselves.’
    Gold open access

    And that is exactly what they did, helped by a Dutch government that suggested ‘gold open access’ as the norm. ‘It’s undoubtedly linked to the fact that many of these publishers, such as Elsevier and Kluwer, have Dutch roots’, says Ane van der Leij, head of research support at the UB.

    ‘Gold’ means you don’t make the whole publishing process free – that would be the diamond option. Instead, a university pays APCs up front for its researchers, and in exchange publishers make their articles available to everyone.

    That’s great for the general public, which can now read those articles for free. But it’s not so great for the universities that still provide research papers and edit academic articles without any payment. ‘And the APCs are high’, Stahl says. ‘In some cases, I estimate there’s a profit margin of 75 percent.’

    Not all magazines are open access, either. Most of the traditional journals are a hybrid now – the content for which APCs have been paid are open access; the rest is still behind a paywall. ‘Unfortunately “hybrid” has become the new status quo for most of these publishers’ journals, and it has become a very profitable business model’, Van der Leij says.
    Package deals

    These days, publishers negotiate ‘read and publish’ package deals for their titles, which have become around 20 percent more expensive in five years. ‘Taking into account an average inflation rate of 3 percent per year over this period, that amounts to a price increase of approximately 12.6 percent’, says Van der Leij.

    Elsevier has received over 16 million euros in 2024 for their deal with umbrella organisation Universities of the Netherlands. Wily gets almost 5 million, Springer 3.6 million.

    The increase is not the same for all publishers, Van der Leij stresses, and the packages themselves also vary, making it difficult to compare. ‘On top of that, it’s become increasingly difficult to figure out which parts are “read” and which ones are “publish”.’

    Also telling: the maximum number of prepaid publications is reached sooner every year, because universities get fewer publications for their money. ‘Four years ago, we would be sending out our emails that we’d reached the cap halfway through November. Three years ago, we did so in early November. This year, it was at the end of October’, says Van der Leij.
    Commercialised research

    That’s not the biggest issue, though. What is worse is the other part of Elsevier’s business model, which they came up with when they realised they needed other ways to keep making money. And the hottest commodity they could think of was data.

    ‘The entire infrastructure that science builds on is commercialised’, says YAG chairperson Lukas Linsi. ‘They effectively turn science into shareholder returns and dividend payouts, and it’s all public money.’

    Pure, which showcases the research for almost all Dutch universities, used to be an independent Danish startup, but was bought by Elsevier in 2012. The formerly open platform Mendeley was acquired in 2013. SSRN in 2016. In 2017 Elsevier bought bepress, a repository used by six hundred academic institutes. ‘It has given them real time data access’, Gstrein says.

    Publishing is no longer the main focus for RELX and its competitors; instead, they have become data brokers. They sell data to insurance companies for risk analysis, to banks for fraud detection, to universities to assess their performance, and, especially egregious, to the US Immigration Service to target illegal immigrants.
    Less dependent

    Many researchers are worried by this. ‘In the Netherlands, universities tend to be a bit optimistic regarding these companies’, Stahl feels. After all, universities have in the past made plans to develop ‘professional services’ together with Elsevier. ‘They just don’t seem to see the danger.’

    In Germany and France, there is much more awareness about these issues. There, universities are less dependent on the big publishers, or are working to move away from them. ‘If some private parties have access to all this data, then that is a long-term threat to academic freedom. We have to do something about it. We need our own infrastructure’, Stahl says.

    Per the contracts, the publishers aren’t allowed to share data. ‘There is the data processing agreement’, explains Marijke Folgering, head of the UB’s development & innovation department. That’s a legally required document stating how data will be processed. ‘They’re not allowed to just use our data. I’m sure they can find ways to do so anyway, but we also enter into these contracts on a trust basis. If they do abuse it, they hopefully hurt themselves as well.’
    Critical

    Researcher Taichi Ochi with the Open Science Community Groningen has his doubts about their trustworthiness, though. ‘We need to move away from them, or we risk detrimental effects’, he says.

    Linsi points to the deal that academic publisher Taylor and Francis made: they sold the research published in their three thousand academic journals to Microsoft for 10 million dollars, to train their AI models. ‘This is happening now!’

    Folgering and Van der Leij with the UB also worry about the seemingly unending stream of data that is flowing towards the publishers. ‘There are currently no indications that the system is being abused’, says Van der Leij, ‘but we’re getting increasingly concerned.’

    ‘We’re definitely critical of what they’re doing’, Folgering agrees. ‘We’re exploring our options. Several German universities have gone in a different direction. But there are limits to what we can do. We simply don’t have that many developers.’

    The problem, of course, is that both researchers and university management want convenience. They want their publications in these publishers’ prestigious distribution channels. They want their tools and software to work quickly, and it’s all the better if these are available at a relatively low cost. ‘But we just don’t consider what that means in the long run. People underestimate how little choice we still have’, Gstrein says.
    Long-standing reputation

    The researchers don’t have an easy solution on hand. ‘If you want to move ahead in your career, you’re dependent on these companies’, Linsi realises. ‘They don’t decide what is published in their journals, but still, it’s their brands that are really important if you want to move up.’

    Diamond open access journals – like the UG’s own University of Groningen Press, founded in 2015 – may be a solution in the long term, but at this point their reputation just isn’t good enough yet, compared to journals with a long-standing reputation and impact factor.

    The tools the publishers provide do work very well, Linsi admits. Repositories in for example Germany – where universities are a lot less dependent on the big publishers – aren’t nearly as ‘attractive’ as the UG’s Pure.

    And there’s the matter of safety too. Are universities able to build alternatives that are safe and that won’t be vulnerable to hacks? ‘In practice, this is quite difficult’, Linsi says. ‘But other countries show that there is a way back.’
    Alternatives

    The UG could start by using alternatives when possible, he explains. Zotero instead of Mendeley, Firefox instead of Google Chrome. ‘There are alternatives for almost every app we use.’

    And it could – and should – find an alternative for Pure. ‘It’s a good first step’, Linsi feels. ‘It’s relatively easy and it is tangible.’

    In fact, Van der Leij says, the UG is currently working on its own data warehouse that would hold all the UG publications’ data and metadata. ‘It might allow us to stop using Pure and keep a hold of our data.’

    But it would be even better if Dutch – or even European – universities worked together on projects like these, to make sure there’s enough funding and that it is done right. In the long run, Linsi believes, it will probably be cheaper than paying huge sums of money to commercial providers.

    ‘We must understand our own worth’, agrees Taichi Ochi. ‘With the cost of publishing ever increasing, it also impacts how much money we can spend on other activities. We need to move away from a model that is draining money.’

    https://ukrant.nl/magazine/elseviers-stranglehold-on-academia-how-publishers-get-rich-from-our-data

    #science #recherche #université #données #édition_scientifique #publications #publications_scientifiques #Elsevier #business #données_personnelles #Stahl #RELX #Springer #Wiley #Gold_open_access

    –-

    ajouté à la métaliste sur la #publication_scientifique :
    https://seenthis.net/messages/1036396

  • Comme si tout le reste n’était pas déjà suffisant (pour un petit aperçu, vous pouvez rester sur seenthis : https://seenthis.net/tag/elsevier), voici que je découvre que :
    Scientists : Elsevier has a shocking amount of data about you.
    https://fediscience.org/@ct_bergstrom/113010261685808797

    –—

    Welcome to Hotel Elsevier : you can check-out any time you like … not

    In December 2021, Robin Kok wrote a series of tweets about his Elsevier data access request. I did the same a few days later. This here is the resulting collaborative blog post, summarizing our journey in trying to understand what data Elsevier collects; what data Elsevier has collected on us two specifically; and trying to get this data deleted. A PDF version of this blog post is also available.

    Elsevier, data kraken

    Everybody in academia knows Elsevier. Even if you think you don’t, you probably do. Not only do they publish over 2,500 scientific journals, but they also own the citation database Scopus, as well as the ScienceDirect collection of electronic journals from which you get your papers. That nifty PURE system your university wants you to use to keep track of your publications and projects? You guessed it: Elsevier. And what about that marvelous reference manager, Mendeley? Elsevier bought it in 2013. The list goes on and on.

    But what exactly is Elsevier? We follow the advice of an Elsevier spokesperson: “if you think that information should be free of charge, go to Wikipedia”. Let’s do that! Wikipedia, in their core summary section, introduces Elsevier as “a Netherlands-based academic publishing company specializing in scientific, technical, and medical content.”

    The intro continues:

    And it’s not just rent-seeking. Elsevier admitted to writing “sponsored article compilation publications, on behalf of pharmaceutical clients, that were made to look like journals and lacked the proper disclosures“; offered Amazon vouchers to a select group of researchers to submit five star reviews on Amazon for certain products; manipulated citation reports; and is one of the leading lobbyists against open access and open science efforts. For this, Elsevier’s parent company, RELX, even employs two full-time lobbyists in the European Parliament, feeding “advice” into the highest levels of legislation and science organization. Here is a good summary of Elsevier’s problematic practices—suffice it to say that they’re very good at making profits.

    As described by Wikipedia, one way to make profits is Elsevier’s business as an academic publisher. Academics write articles for Elsevier journals for free and hand over copyright; other academics review and edit these papers for free; and Elsevier then sells these papers back to academics. Much of the labor that goes into Elsevier products is funded by public money, only for Elsevier to sell the finished products back e.g. to university libraries, using up even more public money.

    But in the 2020s—and now we come to the main topic of this piece—there is a second way of making money: selling data. Elsevier’s parent company RELX bills itself as “a global provider of information-based analytics and decision tools for professional and business customers”. And Elsevier itself has been busy with rebranding, too:

    This may sound irrelevant to you as a researcher, but here we show how Elsevier helps them to monetize your data; the amount of data they have on you; and why it will require major steps to change this troubling situation.
    Data access request

    Luckily, folks over at Elsevier “take your privacy and trust in [them] very seriously”, so we used the Elsevier Privacy Support Hub to start an “access to personal information” request. Being in the EU, we are legally entitled under the European General Data Protection Regulation (GDPR) to ask Elsevier what data they have on us, and submitting this request was easy and quick.

    After a few weeks, we both received responses by email. We had been assigned numbers 0000034 and 0000272 respectively, perhaps implying that relatively few people have made use of this system yet. The emails contained several files with a wide range of our data, in different formats. One of the attached excel files had over 700,000 cells of data, going back many years, exceeding 5mb in file size. We want to talk you through a few examples of what Elsevier knows about us.
    They have your data

    To start with, of course they have information we have provided them with in our interactions with Elsevier journals: full names, academic affiliations, university e-mail addresses, completed reviews and corresponding journals, times when we declined review requests, and so on.

    Apart from this, there was a list of IP addresses. Checking these IP addresses identified one of us in the small city we live in, rather than where our university is located. We also found several personal user IDs, which is likely how Elsevier connects our data across platforms and accounts. We were also surprised to see multiple (correct) private mobile phone numbers and e-mail addresses included.

    And there is more. Elsevier tracks which emails you open, the number of links per email clicked, and so on.

    We also found our personal address and bank account details, probably because we had received a small payment for serving as a statistical reviewer1. These €55 sure came with a privacy cost larger than anticipated.

    Data called “Web Traffic via Adobe Analytics” appears to list which websites we visited, when, and from which IP address. “ScienceDirect Usage Data” contains information on when we looked at which papers, and what we did on the corresponding website. Elsevier appears to distinguish between downloading or looking at the full paper and other types of access, such as looking at a particular image (e.g. “ArticleURLrequestPage”, “MiamiImageURLrequestPage”, and “MiamiImageURLreadPDF”), although it’s not entirely clear from the data export. This leads to a general issue that will come up more often in this piece: while Elsevier shared what data they have on us, and while they know what the data mean, it was often unclear for us navigating the data export what the data mean. In that sense, the usefulness of the current data export is, at least in part, questionable. In the extreme, it’s a bit like asking google what they know about you and they send you a file full of special characters that have no meaning to you.

    Going back to what data they have, next up: Mendeley. Like many, both of us have used this reference manager for years. For one of us, the corresponding tab in the excel file from Elsevier contained a whopping 213,000 lines of data, from 2016 to 2022. For the other, although he also used Mendeley extensively for years, the data export contained no information on Mendeley data whatsoever, a discrepancy for which we could not find an explanation. Elsevier appears to log every time you open Mendeley, and many other things you do with the software—we found field codes such as “OpenPdfIn InternalViewer”, “UserDocument Created”, “DocumentAnnotation Created”, “UserDocument Updated”, “FileDownloaded”, and so on.

    They use your data

    Although many of these data points seem relatively innocent at first, they can easily be monetized, because you can extrapolate core working hours, vacation times, and other patterns of a person’s life. This can be understood as detailed information about the workflow of academics – exactly the thing we would want to know if, like Elsevier, our goal was to be a pervasive element in the entire academic lifecycle.

    This interest in academic lifecycle data is not surprising, given the role of Elsevier’s parent company RELX as a global provider of information-based analytics and decision tools, as well as Elsevier’s rebranding towards an Information Analytics Business. Collecting data comes at a cost for a company, and it is safe to assume that they wouldn’t gather data if they didn’t intend to do something with it.

    One of the ways to monetize your data is painfully obvious: oldschool spam email tactics such as trying to get you to use more Elsevier services by signing you up for newsletters. Many academics receive unending floods of unsolicited emails and newsletters by Elsevier, which prompted one of us to do the subject access request in the first place. In the data export, we found a huge list of highly irrelevant newsletters we were unknowingly subscribed to—for one of us, the corresponding part of the data on “communications” has over 5000 rows.

    You agreed to all of this?

    Well, actually, now that you ask, we don’t quite recall consenting to Mendeley collecting data that could be used to infer information on our working hours and vacation time. After all, with this kind of data, it is entirely possible that Elsevier knows our work schedule better than our employers. And what about the unsolicited emails that we received even after unsubscribing? For most of these, it’s implausible that we would have consented. As you can see in the screenshot above, during one day (sorry, night!), at 3:20am, within a single minute, one of us “signed up” to no fewer than 50 newsletters at the same time – nearly all unrelated to our academic discipline.

    Does Elsevier really have our consent for these and other types of data they collected? The data export seems to answers this question, too, with aptly named columns such as “no consent” and “unknown consent”, the 0s and 1s probably marking “yes” or “no”.

    You can check-out any time you like…?

    Elsevier knows a lot about us, and the data they sent us in response to our access request may only scratch the surface. Although they sent a large volume of data, inconsistencies we found (like missing Mendeley data from one of us) make us doubt whether it is truly all the data they have. What to do? The answer seems straightforward: we can just stop donating our unpaid time and our personal and professional data, right? Indeed, more than 20,000 researchers have already taken a stand against Elsevier’s business practices, by openly refusing to publish in (or review / do editorial work for) Elsevier.

    But that does not really solve the problem we’re dealing with here. A lot of your data Elsevier might monetize is data you cannot really avoid to provide as an academic. For example, many of you will access full texts of papers through the ScienceDirect website, which often requires an institutional login. Given that the login is uniquely identifiable, they know exactly which papers you’ve looked at, and when. This also pertains to all of the other Elsevier products, some of which we briefly mentioned above, as well as emails. Many emails may be crucial for you (e.g. from an important journal), and Elsevier logs what emails you open and whether you click on links. Sure, this is probably standard marketing practice and Elsevier is not the only company doing it, but it doesn’t change the fact that as an active academic, you basically cannot avoid giving them data they can sell. In fact, just nominating someone for peer review can be enough to get them on their list. Did you ever realize that for most reviews you’re invited to, you actually never consented to being approached by the given journal?

    Elsevier has created a system where it seems impossible to avoid giving them your data. Dominating or at least co-dominating the market of academic publishing, they exploited free labor of researchers, and charged universities very high amounts of money so researchers could access scientific papers (which, in part, they wrote, reviewed and edited themselves). This pseudo-monopoly made Elsevier non-substitutable, which now allows their transition into a company selling your data.

    Worse, they say that “personal information that is integral to editorial history will be retained for as long as the articles are being made available”, as they write in their supporting information document on data collection and processing we received as part of the access request. What data exactly are integral to editorial history remains unclear.

    If not interacting with Elsevier is not a sustainable solution in the current infrastructure, maybe some more drastic measures are required. So one of us took the most drastic step available on Elsevier’s privacy hub: a deletion of personal information request.

    This was also promptly handled, but leaves two core concerns. First, it is not entirely clear to us what information was retained by Elsevier, for example, because they consider it “integral to editorial history”. And second, how sustainable is data deletion if all it takes to be sucked back into the Elsevier data ecosystem again is one of your colleagues recommending you as a reviewer for one of the 600,000 articles Elsevier publishes per year?

    Conclusion

    Some of the issues mentioned here, such as lack of consent, seem problematic to us from the perspective of e.g. European data protection laws. Is it ok for companies to sign us up to newsletters without consent? Is it ok to collect and retain personal data indefinitely because Elsevier argues it is necessary?

    And when Elsevier writes in the supporting information that they do “not undertake any automated decision making in relation to your personal information” (which may violate European laws), can that be true when they write, in the same document, that they are using personal information to tailoring experiences? “We are using your personal data for […] enhancing your experience of those products, for example by providing personalized recommendations based on your use of the products.”

    We are not legal scholars, and maybe there is no fire here. But from where we stand, there seems to be an awful lot of smoke. We hope that legal and privacy experts can bring clarity to the questions we raise above—because we simply don’t know what to do about a situation that is becoming increasingly alarming.

    https://eiko-fried.com/welcome-to-hotel-elsevier-you-can-check-out-any-time-you-like-not

    #données #édition_scientifique #Scopus #ScienceDirect #RELX #information_analytics #business

  • La marge opérationnelle d’ #Elsevier a atteint les 38 % en 2023 !

    Elsevier, branche « Scientific, Technical & Medical » du groupe #RELX maintenant, a augmenté cette marge de 3 % entre 2022 et 2023 (à monnaie constante)

    https://piaille.fr/@mart1oeil/112212400218066703

    Source :
    RELX, the global provider of information-based analytics and decision tools, reports results for 2023.


    https://www.relx.com/media/press-releases/year-2024/relx-2023-results

    #édition_scientifique #business #recherche #marché #résultats

    Pour donner suite à la discussion sur sci-hub... ping @ericw @freakonometrics @ant1

  • Un chiffre d’affaires de 8,3 milliards € pour #RELX (#Elsevier) en 2017
    https://www.actualitte.com/article/monde-edition/un-chiffre-d-affaires-de-8-3-milliards-pour-relx-elsevier-en-2017/87344

    RELX, ex-Elsevier, parmi les plus importants groupes éditoriaux du monde, ne connaît pas la crise : son rapport annuel pour 2017 annonce un chiffre d’affaires de 8,395 milliards €, en hausse de 4 %, et des bénéfices de 2,6 milliards €. Si le géant de l’édition académique et de l’organisation d’événements s’inquiète d’une tendance de la recherche à prôner l’accès ouvert, ses résultats économiques restent stables année après année.

    Frankfurt Book Fair - Elsevier
    Elsevier, désormais connu sous le nom RELX (ActuaLitté, CC BY SA 2.0)

    #édition_scientifique #crapules

    L’édition académique se porte bien, du moins est-ce le cas pour RELX. Le groupe éditorial, spécialisé dans ce domaine, fait état d’un chiffre d’affaires en hausse de 4 % et stable par rapport aux dernières années : en 2015, le groupe que l’on nommait alors Reed Elsevier annonçait déjà des revenus de plus de 8 milliards €. Les bénéfices sont eux aussi au beau fixe, à 2,6 milliards €, en hausse de 6 %.

  • Reed Elsevier deviendrait RELX group, et se tourne vers le Big data
    https://www.actualitte.com/economie/reed-elsevier-deviendrait-relx-group-et-se-tourne-vers-le-big-data-55524
    /images/facebook/cb9825de4ece4b0828e3b9e9dc86c144.jpg

    Erik Engstrom, directeur exécutif de Reed Elsevier, désormais RELX, a signalé que les résultats 2015 devraient suivre la même évolution que ceux de l’année précédente. Le changement de nom, qui doit être validé par les actionnaires au mois d’avril prochain, ira de pair avec un rachat de 500 millions £ de ses propres actions, et un virage des investissements vers l’activité Big data du groupe.

    « Ce nom sera, selon la société, une meilleure incarnation de sa transformation d’un éditeur de journaux et de livres papier en un fournisseur d’informations numériques », peut-on ainsi lire sur le site du groupe. Les actionnaires ont validé les différents investissements de Reed dans l’industrie des Big data, et l’action est désormais évaluée à 22,72 €, alors qu’elle s’arrêtait à 15,16 € il y a un an.

    L’édition académique, juridique, scientifique ou médicale a donc fourni des résultats peu dynamiques pour cette année 2014. Cela n’étonne pas vraiment les actionnaires : l’open access et les nouveaux modèles économiques du secteur ont mis à mal les activités de Reed Elsevier, ou du moins les chahutent un peu. Ainsi, aux Pays-Bas, « pays natal » de Elsevier, les organisations universitaires ont lancé un boycott contre le groupe, qu’ils jugent trop hostile à l’open access.